United States Natural Gas Fund vs Zoetis Inc — how do they compare? United States Natural Gas Fund trades at $11.01 (market cap $517.27M), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 58.4× United States Natural Gas Fund's market cap, and Zoetis Inc pays a 2.9% dividend while United States Natural Gas Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold United States Natural Gas Fund for 22 Days and Zoetis Inc for 70 Days on average.
| UNG | ZTS | |
|---|---|---|
Market Cap | $517.27M | $30.20B |
Volume | 29,485,537 | 6,175,327 |
Sector | Commodities - Energy | Health |
52-Week High | $16.90 | $147.53 |
52-Week Low | $9.63 | $69.09 |
Typical Hold Time | 22 Days | 70 Days |
Enterprise Value | — | $37.76B |
Dividend Yield | — | 2.9% |
Signals from Pluang's Aura AI — not financial advice
UNG trades at $10.81, down 1.99% today, with a bullish technical signal from moving averages but neutral oscillators. The company reported strong net income of $65.15M for 2024 despite zero revenue, with robust cash flow from operations of $47.54M. Recent news highlights natural gas market volatility driven by record production and geopolitical tensions.
The outlook is mixed: technical momentum supports near-term upside, but fundamental concerns arise from zero revenue and negative net cash flow. Risks include commodity price sensitivity and geopolitical factors affecting natural gas markets. Analyst sentiment leans bullish on technicals but requires fundamental improvement for sustained growth.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal despite mixed moving averages and oscillators. The company shows strong profitability with a 27.69% net income margin and 64.91% ROE, though recent quarterly earnings have been inconsistent. Analyst consensus is a $87.33 price target with no sell ratings. Recent news highlights near-term headwinds in U.S. companion animal sales but underscores long-term resilience and undervaluation.
ZTS presents a compelling value opportunity with a low P/E of 11.92 and robust margins, but faces risks from competitive pressures and volatile earnings. Upside potential exists if the company executes on international growth and maintains its industry-leading profitability, though investors should monitor Q3 2026 results for confirmation of recovery trends.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
UNG is a commodity ETF that tracks the daily price movements of natural gas futures. It primarily invests in front-month contracts at the Henry Hub, making it a highly volatile tool for short-term trading rather than long-term holding due to contango and roll costs.
Read more on UNG →Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →